AGIOS PHARMACEUTICALS INC. - COMMON STOCK

Agios Appoints Richa Poddar as Chief Commercial Officer

15 11 2021 15:01:00 提供 Nasdaq GlobeNewswire

Agios to Present Broad Set of Clinical and Translational Data in Chronic Hemolytic Anemias at 63rd ASH Annual Meeting and Exposition

04 11 2021 08:00:01 提供 Nasdaq GlobeNewswire

Agios Reports Business Highlights and Third Quarter 2021 Financial Results

03 11 2021 06:10:58 提供 Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Third Quarter 2021 Financial Results on Nov. 3, 2021

21 10 2021 15:01:00 提供 Nasdaq GlobeNewswire

Agios To Present at September Investor Conferences

30 8 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency

17 8 2021 15:01:00 提供 Nasdaq GlobeNewswire

Agios Reports Business Highlights and Second Quarter 2021 Financial Results

29 7 2021 06:00:03 提供 Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021

15 7 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency

28 6 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Launches myAgios® Patient Support Services for Pyruvate Kinase Deficiency

22 6 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency

21 6 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress

11 6 2021 02:00:00 提供 Nasdaq GlobeNewswire

Agios Announces Updated Data from ACTIVATE and ACTIVATE-T Phase 3 Studies of Mitapivat in Pyruvate Kinase (PK) Deficiency at the European Hematology Association Virtual Congress

11 6 2021 02:00:00 提供 Nasdaq GlobeNewswire

Agios to Present Updated Data from Clinical Trials of Mitapivat in Pyruvate Kinase Deficiency and Thalassemia in Oral Presentations at the European Hematology Association Annual Congress

12 5 2021 09:00:00 提供 Nasdaq GlobeNewswire

Agios Reports Business Highlights and First Quarter 2021 Financial Results

29 4 2021 06:00:01 提供 Nasdaq GlobeNewswire

Agios to Webcast Conference Call of First Quarter 2021 Financial Results on April 29, 2021

15 4 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Announces Closing of Oncology Business Sale to Servier

01 4 2021 06:00:00 提供 Nasdaq GlobeNewswire

Agios Shareholders Approve Sale of Oncology Business to Servier

25 3 2021 15:01:00 提供 Nasdaq GlobeNewswire

Agios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease

18 3 2021 06:00:01 提供 Nasdaq GlobeNewswire

Agios Submits Supplemental New Drug Application to FDA for TIBSOVO® (ivosidenib tablets) for Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma

01 3 2021 06:00:01 提供 Nasdaq GlobeNewswire